Skip to content
Business Finance

MBK Partners and Young Poong Expand Stake in Korea Zinc to 46.7% of Voting Shares

MBK Partners 2 mins read

Strategic Move Solidifies Control and Strengthens Governance


SEOUL, South Korea--BUSINESS WIRE--

MBK Partners, through its special-purpose company, Korea Corporate Investment Holdings Co., Ltd., has acquired an additional 1.13% stake in Korea Zinc.

This latest acquisition increases MBK Partners and Young Poong’s combined stake in Korea Zinc to 40.97% of the total issued shares and 46.7% of the voting shares, excluding treasury stock, positioning the group closer to majority control.

According to disclosures from the Financial Supervisory Service’s electronic reporting system, Korea Corporate Investment Holdings purchased 234,451 shares (1.13% of Korea Zinc’s total issued shares) through open-market trading under the "Careful Discretion" (CD) method between November 12 and December 18.

With this transaction, Korea Corporate Investment Holdings now independently holds 7.82% of Korea Zinc's total issued shares (8.9% of voting shares). This includes the 5.32% stake acquired via a tender offer completed on October 14 and a 1.36% stake purchased on the open market last month. Combined with Young Poong and related parties’ existing 33.13% stake, as well as an additional 0.02% Young Poong acquired through the tender offer, MBK Partners and Young Poong have expanded their position as the largest shareholders of Korea Zinc.

An MBK Partners representative commented, “This acquisition lays a strong foundation for reclaiming our rights as the largest shareholder, including management control rights which legitimately belong to the largest shareholder, and serves as a pivotal step towards strengthening the company’s corporate governance.”


Contact details:

For media inquiry:
Seikyu Hong, Head of Communications, MBK Partners
+82 10 8944 7798
sk.hong@mbkpartnerslp.com

Media

More from this category

  • Business Finance
  • 17/01/2025
  • 05:26
Philip Morris International

FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.

FDA decision makes ZYN the first authorized nicotine pouch productScience-based decision affirms that ZYN nicotine pouches are a better alternative for adults who smoke or use other traditional tobacco products RICHMOND, Va.--BUSINESS WIRE-- The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+. “An estimated 45…

  • Business Finance
  • 17/01/2025
  • 03:41
Alvarez & Marsal

Alvarez & Marsal Announces 2025 Managing Director Promotions

NEW YORK--BUSINESS WIRE-- Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 80 professionals, across Brazil, Canada, France, Germany, India, Italy, Spain, Sweden, United Arab Emirates, United Kingdom, and the United States, to the position of Managing Director. Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “All of our newly promoted Managing Directors embody the talent and leadership necessary to deliver exceptional results that create value for A&M’s clients. Their contributions to the growth of our firm and the clients we serve cannot be understated. From around the world and across our many lines…

  • Business Finance
  • 17/01/2025
  • 02:11
Arturo

Data Shows AI Helps Insurers and Homeowners Navigate the Climate Crisis

New research highlights how AI-driven insight repairs trust and improves collaboration in the wake of increased natural disasters SALT LAKE CITY–BUSINESS WIRE– As climate-driven…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.